Most Read

  • 21 May 2019

    The top selling prescription drugs by revenue

    Humira tops the list despite growing biosimilar competition, while Opdivo and Keytruda, the new-age checkpoint inhibitors for cancer have grown in terms of market share and revenue generation since their...

  • 21 November 2018

    Pharma Technology Focus – Issue 77

    In this issue: China’s growing pharmaceutical market, antimicrobial resistance, the rise of tech giants in healthcare, and more.

  • 20 September 2018

    Pharma Technology Focus – Issue 75

    In this issue: Making manufacturing work in gene and cell therapies, AI generated compounds, clinical trial transparency in the Americas, and more.

  • 19 July 2018

    Pharma Technology Focus – Issue 73

    In this issue: Major investment signals confidence in the search for new products developed from DNA found in soil, a medical milestone for cannabinoids in the US, streamlining clinical research,...

  • 27 June 2018

    Pharma Technology Focus – Issue 72

    In this issue: Overcoming red tape in China, how to boost adoption of biosimilars in the US, a profile of global health research network TriNetX, unlocking cell-free protein synthesis, and...

  • 27 February 2018

    Pharma Technology Focus – Issue 68

    In this issue: The benefits of seamless clinical trials, a new functional cure for HIV, using mRNA to target cancer tumours, the potential of magnetic hyperthermia in killing cancerous cells,...

  • 24 January 2018

    Pharma Technology Focus – Issue 67

    In this issue: How cancer drug resistance works, accessing funding for rare diseases, India’s attempt to redefine over the counter drugs, the biotech potential of slipper limpets, Dundee University’s influence...

Close
Close
Close

Go Top